Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coal tar

This article was originally published in The Tan Sheet

Executive Summary

Trial in California Prop 65 litigation over use of coal tar in dandruff shampoos and other OTCs stayed until Jan. 29. Consolidated trial in separate lawsuits brought by the state and Perry Gottesfeld had been slated to begin Oct. 10, but Bergen Brunswig and Reedco requested a stay pending FDA review of the ingredient's safety (1"The Tan Sheet" Sept. 4, p. 16). Other defendants include J&J's Neutrogena division and Denorex shampoo marketer Whitehall-Robins. Reedco is a subsidiary of Tegrin manufacturer Block Drug, which SmithKline Beecham is acquiring for roughly $1.24 bil

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091788

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel